Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction

Size: px
Start display at page:

Download "Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction"

Transcription

1 Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction Holger Thiele, MD; Konrad Kubusch, BSc; Steffen Desch, MD; Oliver Strohm*, MD, Georg Fuernau, MD;, Suzanne de Waha, MD; Matthias Gutberlet, MD; Gerhard Schuler, Matthias G. Friedrich*, MD and Ingo Eitel, MD University of Leipzig Heart Center, Germany *University of Calgary, Canada

2 Disclosures Prognostic Value of Intramyocardial Hemorrhage Detected by Cardiac Magnetic Resonance Imaging in Acute Reperfused ST-Elevation Myocardial Infarction Nothing to disclose for any of the authors

3 Infarct size (%) Background Effects of Reperfusion No Reperfusion Infarct size % Reperfusion Infarct size reduction by 40% Partly by reperfusion injury + hemorrhage Reperfusion plus cardio protection Infarct size 5% Adapted according to Yellon et al. NEJM 2007; 357:

4 Event-free survival (%) Event-free survival (%) Background Late MO + MACE Presence of late MO Extent of late MO p< p< no MO 20 MO Time to event (months) Tertile 1 Tertile 2 Tertile Time to event (months) De Waha et al. Eur Heart J 2010; doi: /eurheartj/ehq247

5 Background Hemorrhage in MRI Microvascular obstruction is known to be a independent powerful of adverse outcome. Recently, intramyocardial hemorrhage has been introduced as a new potential CMR parameter in STEMI patients Hemorrhage can be visualized by T2-weighted and/or T2*-weighted CMR -breakdown products of hemoglobin are paramagnetic and -influence regional magnetic tissue properties The hypointense core in T2/Hemorrhage is related to adverse remodeling. Additional prognostic value for clinical events of hemorrhage in T2-weighted images? Ganame et al. Eur Heart J 2009;30, O Regan et al. Radiology 2009;250:

6 Background Hypointense Core in T2 (Hemorrhage) Lotan et al Circulation 1992;86; Basso et al Am J Cardiol 2008;100; Ganame et al Eur Heart J 2009;30,

7 Aims To evaluate the prognostic value and determinants of a hypointense core in T2-weighted imaging in STEMI patients reperfused by primary PCI

8 Methods Hemorrhage Study 62 patients 346 STEMI patients 284 patients

9 Methods Trial Profile Eligible STEMI patients < 12 h (n=407) No inclusion (n=4): No informed consent (n=4) No CMR (n=57): Claustrophobia (n=19) Death (n=14) Technical reasons (n=7) Refusal (n=6) Patient discomfort (n=6) Obesity (n=5) CMR (n=346) Hypointense core in T2 CMR present (n=122) Hypointense core in T2 CMR absent (n=224) Lost to 6 month follow-up (n=2) Endpoint analysis (n=120) Lost to 6 month follow-up (n=9) Endpoint analysis (n=213)

10 Methods Endpoint Analysis Primary composite endpoint (MACE): Death Myocardial re-infarction New-onset CHF (requiring hospital admission) Follow-up was conducted after 6 months

11 Methods MR Image Acquisition Contrast-injection 2 mmol/kg/bw Bolus Gadobutrol i.v CH+2 CH T2 SA DE early SA Short axes 30 DE late 4CH+2CH+SA Time (min) Survey SSFP sequence (TR/TE/flip = 3.2/1.2/60 ) 3D IR GRE sequence (TR/TE/flip 2.8/1.1/15 ) Thiele et al. JACC 2010; 2010;55:

12 Methods MR Image Analysis Blinded observers: Manual drawing of Edema, endocardial, epicardial, papillary, Infarcted MO Hemorrhage contours Area at risk = Volume Edema/Volume LV mass %Infarct Size = Volume Infarct/Volume LV mass %MO = MO-Volume/Volume LV mass %Hemorrhage = T2 hypointense core/volume LV mass Myocardial salvage = Edema-Infarct Size Myocardial salvage index = Edema-Infarct Size/Edema Thiele et al. JACC 2010; 2010;55: Eitel et al. JACC 2010; 55:

13 Results Patient Characteristics Variable All patients (n=346) Hypo Core present (n=122) No Hypo Core (n=224) p-value Age (years) 64 (53-73) 62 (53-72) 65 (54-73) 0.29 Male sex; No. (%) 256 (74) 94 (77) 162 (72) 0.34 Cardiovascular risk factors; No. (%) Current Smoking Hypertension Hypercholesterolemia Diabetes mellitus 140 (41) 222 (64) 121 (35) 78 (23) 56 (46) 76 (62) 40 (33) 29 (24) 84 (38) 146 (65) 81 (36) 49 (22) Anterior myocardial infarction; No. (%) 158 (46) 65 (53) 93 (42) 0.04 Reperfusion times (minutes) Symptom-onset-to-reperfusion Door-to-balloon time 194 ( ) 28 (20-36) 190 ( ) 26 (20-35) 180 ( ) 28 (22-36) TIMI-flow grade before PPCI 1; No. (%) 244 (71) 106 (87) 138 (62) <0.001 TIMI-flow grade after PPCI < 3; No. (%) 33 (10) 18 (15) 15 (7) 0.03 Glycoprotein IIb/IIIa-inhibitor; No. (%) 322 (93) 117 (96) 205 (92) Medication at discharge; No. (%) Beta-blockers ACE-inhibitors/AT-1 antagonist Aspirin Clopidogrel Statins Aldosterone antagonist 341 (99) 342 (99) 346 (100) 346 (100) 341 (99) 11 (3) 120 (98) 121 (99) 122 (100) 122 (100) 120 (98) 6 (5) 221 (99) 221 (99) 224 (100) 224 (100) 221 (99) 4 (2)

14 Results MRI Results Variable Hypo Core present (n=122) No Hypo Core (n=224) p- value Area at risk/edema (%LV) 38.9 ( ) 32.2 ( ) <0.001 Infarct size (%LV) 27.1 ( ) 13.0 ( ) <0.001 Late MO present; No (%) 122 (100) 108 (48) <0.001 Late MO (%LV) 2.1 ( ) 0.1 ( ) <0.001 Myocardial salvage (%LV) 11.5 ( ) 15.8 ( ) <0.001 Myocardial salvage index 28.5 ( ) 58.1 ( ) <0.001 LV ejection fraction (%) 46.8 ( ) 57.0 ( ) <0.001 LV enddiastolic volume (ml) ( ) ( ) <0.001 LV endsystolic volume (ml) 77.4 ( ) 55.0 ( ) <0.001

15 Results Logistic Regression for Hypo Core Presence Predictors Univariable Stepwise Multivariable OR 95% CI p HR 95% CI p Age (years) Male sex Current smoking Hypertension Hypercholesterolemia Diabetes mellitus Anterior myocardial infarction Door-to-balloon time (min) Symptoms-reperfusion time (min) TIMI-flow grade before PCI < TIMI-flow after PCI < Area at risk (%LV) < Infarct size (%LV) < Myocardial Salvage Index < Extent late MO (%LV) < <0.001 LV ejection fraction (%) <

16 Results Endpoint Analysis Overall 35 MACE events recorded: - death: 12 patients - myocardial reinfarction: 10 patients - new congestive CHF: 13 patients MACE-rate: 10.5%

17 Cumulative event rate (%) Cumulative event rate (%) Results Hypointense Core vs. MO + Outcome 20 Hypointense core MO + 10 Hypointense core MO - 0 log-rank test p= Time (days after infarction) log-rank test p= Time (days after infarction)

18 Results Patient Examples MO Hypo Core - N=116 MO + Hypo Core + N=122 T2 DE MO + Hypo Core N=108

19 Cumulative event rate (%) Results Hypointense Core + MO and Outcome 20 MO + and hypointense core + 15 MO only MO - and hypointense core - 0 log-rank test p= Time (days after infarction)

20 Results Predictors of MACE Uni - + stepwise multivariable Cox-regression analysis Univariable Stepwise multivariable Variable Hazard Ratio (95% CI) p Hazard Ratio (95% CI) p Age 1.04 ( ) ( ) TIMI-flow after PCI < ( ) Presence late MO 4.23 ( ) ( ) 0.03 Presence hypointense core 2.59 ( ) Infarct size > median 2.39 ( ) LV-EF < median 3.01 ( ) ( ) 0.04

21 Results Predictors of MACE MO Hypo Core Uni - + stepwise multivariable Cox-regression analysis Univariable Stepwise multivariable Variable Hazard Ratio (95% CI) p Hazard Ratio (95% CI) p Age 1.04 ( ) ( ) TIMI-flow after PCI < ( ) Presence late MO only 1.19 ( ) Presence hypointense core + late MO 2.59 ( ) ( ) 0.04 Infarct size > median 2.39 ( ) LV-EF < median 3.01 ( ) ( ) 0.04

22 Prognostic relevance Prognostic Implications Prognostic relevance validated Prognostic relevance validated Prognostic relevance validated Prognostic relevance partly validated Prognostic relevance partly validated Hemorrhage Myocardial salvage LV volumes + ejection fraction Infarct size Microvascular obstruction

23 Limitations: T2* vs T2 A B A B C D C D E ROI 1: T2* = 20±1 ms EF E ROI 1: T2* = 19.9±0.8 ms F ROI 1: T2* = 32±2 ms ROI 1: T2* = 7.8±0.4 ms Cannan, Eitel et al. JACC Img. 2010;3;

24 Summary + Conclusions A hypointense core within the AAR of reperfused infarcted myocardium in T2-weighted CMR is a frequent finding (1/3 of patients) in reperfused STEMI patients. It is closely related to infarct size and MO. A hypointense core in T2-weighted images adds prognostic information on top of MO with regard to MACE. However, larger trials are warranted to further investigate the prognostic significance of hypointense infarct cores.

25 Thank you for your attention

Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention

Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention Cardiac Magnetic Resonance Substudy of the AIDA STEMI trial Holger Thiele, MD; Jochen

More information

Ingo Eitel 1*, J. Pöss 1, A. Jobs 1, C. Eitel 1, S. de Waha 1, J. Barkhausen 2, S. Desch 1 and H. Thiele 1

Ingo Eitel 1*, J. Pöss 1, A. Jobs 1, C. Eitel 1, S. de Waha 1, J. Barkhausen 2, S. Desch 1 and H. Thiele 1 Eitel et al. Journal of Cardiovascular Magnetic Resonance (2015) 17:62 DOI 10.1186/s12968-015-0161-x RESEARCH Open Access Left ventricular global function index assessed by cardiovascular magnetic resonance

More information

Early administration of reperfusion therapy improves survival. Original Articles

Early administration of reperfusion therapy improves survival. Original Articles Original Articles Prognostic Value and Determinants of a Hypointense Infarct Core in T2-Weighted Cardiac Magnetic Resonance in Acute Reperfused ST-Elevation Myocardial Infarction Ingo Eitel, MD; Konrad

More information

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction the Randomized SHOCK-COOL Trial

Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction the Randomized SHOCK-COOL Trial Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction the Randomized SHOCK-COOL Trial Georg Fuernau, Johannes Beck, Steffen Desch, Ingo Eitel, Christian Jung, Sandra Erbs, Norman Mangner,

More information

Introduction. Aims. Keywords myocardial infarction prognosis electrocardiogram cardiac magnetic resonance

Introduction. Aims. Keywords myocardial infarction prognosis electrocardiogram cardiac magnetic resonance European Heart Journal Cardiovascular Imaging (2016) 17, 194 202 doi:10.1093/ehjci/jev135 QRS complex distortion (Grade 3 ischaemia) as a predictor of myocardial damage assessed by cardiac magnetic resonance

More information

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa Stockholm Aug 29, 2010 Role of MRI in the acute Myocardial Infarction? massimo lombardi Two days after infarct (top row), the T2 hyperintense

More information

Influence of Location and Size of Myocardial Infarction on Post-infarction Remodelling

Influence of Location and Size of Myocardial Infarction on Post-infarction Remodelling Influence of Location and Size of Myocardial Infarction on Post-infarction Remodelling Masci PG, MD ; Ganame J, MD ; Francone M, MD, PhD # ; Desmet W, MD ; Iacucci I, MD # ; Barison A, MD ; Carbone I,

More information

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR

Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR Acute Myocarditis Mimicking ST-segment Elevation Myocardial Infarction: Relation Between ECG Changes And Myocardial Damage As Assessed By CMR G. Nucifora 1, A. Di Chiara 2, D. Miani 1, G. Piccoli 3, M.

More information

IMR in acute STEMI and clinical outcomes

IMR in acute STEMI and clinical outcomes IMR in acute STEMI and clinical outcomes Professor Colin Berry Golden Jubilee National Hospital, University of Glasgow. ETP Coronary Physiology 24 April 2015 Disclosures Speaker - Shire Pharmaceuticals,

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and perfusion

Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and perfusion Multidisciplinary Cardiovascular Research Centre Leeds Institute of Genetics, Health and Therapeutics Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and

More information

University of Leipzig Heart Center

University of Leipzig Heart Center Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock Holger

More information

Supplementary Table S1: Proportion of missing values presents in the original dataset

Supplementary Table S1: Proportion of missing values presents in the original dataset Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)

More information

The Strategic Reperfusion Early After STEMI study Implications for clinical practice

The Strategic Reperfusion Early After STEMI study Implications for clinical practice The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional

More information

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The

More information

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. GENNARO SARDELLA, MD, FACC,FESC; MASSIMO MANCONE,

More information

Pharmaco-Invasive Approach for STEMI

Pharmaco-Invasive Approach for STEMI Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),

More information

Rational use of imaging for viability evaluation

Rational use of imaging for viability evaluation EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium

More information

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants

More information

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice 10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia

More information

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia THE VALUE OF 24 H HEART RATE VARIABILITY IN PREDICTING THE MODE OF DEATH IN PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION IN BETA-BLOCKING BLOCKING ERA Arbolishvili GN, Mareev VY Institute of Clinical

More information

Patient characteristics Intervention Comparison Length of followup

Patient characteristics Intervention Comparison Length of followup ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing

More information

Bivalirudin should be indicated for all patients with STEMI. Adnan Kastrati Deutsches Herzzentrum, Munich, Germany

Bivalirudin should be indicated for all patients with STEMI. Adnan Kastrati Deutsches Herzzentrum, Munich, Germany Bivalirudin should be indicated for all patients with STEMI Adnan Kastrati Deutsches Herzzentrum, Munich, Germany 1 Heparin+IIb/IIIa, heparin alone or bivalirudin in STEMI: Do we have the answer? 2 Heparin+IIb/IIIa,

More information

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION PCI Hospital Ambulance/ER STREAM design STEMI

More information

Φαινόμενο No-Reflow. Απεικόνιση με CMR, κλινική συσχέτιση και προγνωστική σημασία

Φαινόμενο No-Reflow. Απεικόνιση με CMR, κλινική συσχέτιση και προγνωστική σημασία Φαινόμενο No-Reflow. Απεικόνιση με CMR, κλινική συσχέτιση και προγνωστική σημασία Θεόδωρος. Καραμήτσος MD PhD Honorary Consultant in Cardiology University of Oxford Centre for Clinical Magnetic Resonance

More information

Shock Index as a Predictor of Myocardial Damage and Clinical Outcome in ST-Elevation Myocardial Infarction

Shock Index as a Predictor of Myocardial Damage and Clinical Outcome in ST-Elevation Myocardial Infarction 924 REINSTADLER SJ et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Ischemic Heart Disease Shock Index as a Predictor of Myocardial

More information

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,

More information

STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury.

STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Hospital Clínico San Carlos.

More information

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine

More information

Early discharge in selected patients after an acute coronary syndrome can it be safe?

Early discharge in selected patients after an acute coronary syndrome can it be safe? Early discharge in selected patients after an acute coronary syndrome can it be safe? Glória Abreu, Pedro Azevedo, Carina Arantes, Catarina Quina-Rodrigues, Sara Fonseca, Juliana Martins, Catarina Vieira,

More information

International Journal of Cardiology

International Journal of Cardiology International Journal of Cardiology 167 (2013) 2047 2054 Contents lists available at ScienceDirect International Journal of Cardiology journal homepage: www.elsevier.com/locate/ijcard Cardiovascular magnetic

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden

More information

ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial

ARMYDA-RECAPTURE (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) trial ARMYDA-RECAPTURE ( for Reduction of MYocardial Damage during Angioplasty) trial Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic

More information

Severe Left Ventricular Dysfunction: Evolving Revascularization Strategies

Severe Left Ventricular Dysfunction: Evolving Revascularization Strategies Severe Left Ventricular Dysfunction: Evolving Revascularization Strategies Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern

More information

STEMI Presentation and Case Discussion. Case #1

STEMI Presentation and Case Discussion. Case #1 STEMI Presentation and Case Discussion Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando, Florida September 17 th,

More information

A Future for the IABP in Cardiogenic Shock? Holger Thiele Medical Clinic II (Cardiology/Angiology/Intensive Care) University of Lübeck, Germany

A Future for the IABP in Cardiogenic Shock? Holger Thiele Medical Clinic II (Cardiology/Angiology/Intensive Care) University of Lübeck, Germany A Future for the in Cardiogenic Shock? Holger Thiele Medical Clinic II (Cardiology/Angiology/Intensive Care) University of Lübeck, Germany Disclosures Funding: German Research Foundation German Heart Research

More information

Cardiology Department Coimbra Hospital and Medical School Portugal

Cardiology Department Coimbra Hospital and Medical School Portugal Quantitative troponin elevation provide incremental prognostic value beyond comprehensive risk stratification in patients with acute coronary syndromes. Rui Baptista, Elisabete Jorge, Hélia Martins, Fátima

More information

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl #

M/39 CC D. => peak CKMB (12 hr later) ng/ml T.chol/TG/HDL/LDL 180/150/48/102 mg/dl # Acute Coronary Syndrome - Case Review - Young-Guk Ko, MD Yonsei Cardiovascular Center Yonsei University College of Medicine Case 1 M/39 #4306212 CC D : Severe squeezing chest pain : 4 hours, aggravated

More information

Advanced MR Imaging in Myocarditis

Advanced MR Imaging in Myocarditis Naeem Merchant MD FRCP Professor of Medicine Department of Radiology Department of Cardiac Sciences Cumming School of Medicine University of Calgary Advanced MR Imaging in Myocarditis The Lake Louise Criteria

More information

Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial Infarction

Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial Infarction Original Article Platelet Reactivity and Intramyocardial Hemorrhage in Patients With ST-Segment Elevation Myocardial Infarction Clinical and Applied Thrombosis/Hemostasis 2014, Vol. 20(5) 553-558 ª The

More information

Recovering Hearts. Saving Lives.

Recovering Hearts. Saving Lives. Recovering Hearts. Saving Lives ṬM The Door to Unload (DTU) STEMI Safety & Feasibility Pilot Trial November 218 Recovering Hearts. Saving Lives. LEGAL DISCLAIMERS This presentation includes select slides

More information

Coronary Artery Disease

Coronary Artery Disease Coronary Artery Disease rognostic Relevance of apillary Muscle Infarction in Reperfused Infarction as Visualized by Cardiovascular Magnetic Resonance Ingo Eitel, MD; Dörthe Gehmlich, MD; Omran Amer, MD;

More information

SOLVE-TAV. Holger Thiele, MD on behalf of the SOLVE-TAVI Investigators

SOLVE-TAV. Holger Thiele, MD on behalf of the SOLVE-TAVI Investigators SOLVE-TAV A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation Holger Thiele, MD on behalf

More information

Is the myocardial blush grade scored by the operator during primary PCI of prognostic value in patients with STEMI in routine clinical practice?

Is the myocardial blush grade scored by the operator during primary PCI of prognostic value in patients with STEMI in routine clinical practice? Is the myocardial blush grade scored by the operator during primary PCI of prognostic value in patients with STEMI in routine clinical practice? Marthe A. Kampinga Department of Cardiology, The Netherlands

More information

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction

Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction Randomized Comparison of Prasugrel and Bivalirudin versus Clopidogrel and Heparin in Patients with ST-Segment Elevation Myocardial Infarction The Bavarian Reperfusion Alternatives Evaluation (BRAVE) 4

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting Ahmed A A Suliman, MBBS, FACP, FESC Associate Professor, University of Khartoum Interventional Cardiologist,

More information

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients? Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at

More information

Journal of the American College of Cardiology Vol. 55, No. 20, by the American College of Cardiology Foundation ISSN /$36.

Journal of the American College of Cardiology Vol. 55, No. 20, by the American College of Cardiology Foundation ISSN /$36. Journal of the American College of Cardiology Vol. 55, No. 20, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.08.091

More information

Thrombus Aspiration in Patients with ST-Elevation Myocardial Infarction Presenting Late after Symptom Onset

Thrombus Aspiration in Patients with ST-Elevation Myocardial Infarction Presenting Late after Symptom Onset Accepted Manuscript Thrombus Aspiration in Patients with ST-Elevation Myocardial Infarction Presenting Late after Symptom Onset Steffen Desch, MD, Thomas Stiermaier, MD, Suzanne de Waha, MD, Philipp Lurz,

More information

Right ventricular injury (RVI) in ST-elevation myocardial

Right ventricular injury (RVI) in ST-elevation myocardial Right Ventricular Injury in ST-Elevation Myocardial Infarction Risk Stratification by Visualization of Wall Motion, Edema, and Delayed-Enhancement Cardiac Magnetic Resonance Matthias Grothoff, MD; Christian

More information

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 9, 2013

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 9, 2013 Adjunctive Antithrombotic for PCI SCAI Fellows Course December 9, 2013 Theodore A Bass, MD FSCAI President SCAI Professor of Medicine, University of Florida Medical Director UF Shands CV Center,Jacksonville

More information

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,

More information

Ticagrelor vs prasugrel in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention

Ticagrelor vs prasugrel in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention DISCLOSURES: NONE Ticagrelor vs prasugrel in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention I. Xanthopoulou, KC. Theodoropoulos, G. Kassimis, V.

More information

Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era

Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era Lack of Effect of Beta-blocker Therapy in Patients with ST-elevation Acute Myocardial Infarction in PCI Era B. Bao 1, N. Ozasa 1, T. Morimoto 2, Y. Furukawa 3, M. Shirotani 4, H. Ogawa 5, C. Tei 6, H.

More information

Despite improvements in STEMI care. The 6 month mortality remains high ~10% 1. Intra-aortic balloon counterpulsation

Despite improvements in STEMI care. The 6 month mortality remains high ~10% 1. Intra-aortic balloon counterpulsation Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: The CRISP AMI Randomized Trial Manesh R. Patel, MD, Richard W. Smalling, MD,

More information

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention

Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention Is it safe to discharge patients 24 hours after uncomplicated successful primary percutaneous coronary intervention DA Jones, J Howard, S Gallagher, KS Rathod, A Jain, S Mohiddin, C Knight, A Mathur, EJ

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :

More information

Pathophysiology of ischemia-reperfusion injury (and how to protect against it )

Pathophysiology of ischemia-reperfusion injury (and how to protect against it ) Pathophysiology of ischemia-reperfusion injury (and how to protect against it ) Dr Derek J Hausenloy Reader in Cardiovascular Medicine BHF Senior Clinical Research Fellow Honorary Consultant Cardiologist

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

Thrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam

Thrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam Seoul, 27 April TCT AP 2010 Thrombus Aspiration before PCI: Routine Mandatory Robbert J de Winter MD PhD FESC Professor Clinical Cardiology Academic Medical Center University of Amsterdam AMC Amsterdam

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

Diabetic Patients: Current Evidence of Revascularization

Diabetic Patients: Current Evidence of Revascularization Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction

More information

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

More information

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction

Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Incidence and Predictors of Stent Thrombosis after Percutaneous Coronary Intervention in Acute Myocardial Infarction Sungmin Lim, Yoon Seok Koh, Hee Yeol Kim, Ik Jun Choi, Eun Ho Choo, Jin Jin Kim, Mineok

More information

Preprocedural TIMI Flow and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty

Preprocedural TIMI Flow and Mortality in Patients With Acute Myocardial Infarction Treated by Primary Angioplasty Journal of the American College of Cardiology Vol. 43, No. 8, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.11.042

More information

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Supplementary Material to Mayer et al. A comparative cohort study on personalised Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass

More information

World Journal of Cardiology. Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction

World Journal of Cardiology. Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction W J C World Journal of Cardiology Submit a Manuscript: http://www.wjgnet.com/esps/ DOI: 10.4330/wjc.v9.i2.109 World J Cardiol 2017 February 26; 9(2): 109-133 ISSN 1949-8462 (online) REVIEW Cardiovascular

More information

Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-Magnetic Resonance Imaging

Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-Magnetic Resonance Imaging Journal of the American College of Cardiology Vol. 47, No. 8, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.065

More information

Current and Future Imaging Trends in Risk Stratification for CAD

Current and Future Imaging Trends in Risk Stratification for CAD Current and Future Imaging Trends in Risk Stratification for CAD Brian P. Griffin, MD FACC Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Disclosures: None Introduction

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

TICAGRELOR VERSUS CLOPIDOGREL AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ST- ELEVATION MYOCARDIAL INFARCTION: A RANDOMIZED CLINICAL TRIAL

TICAGRELOR VERSUS CLOPIDOGREL AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ST- ELEVATION MYOCARDIAL INFARCTION: A RANDOMIZED CLINICAL TRIAL TICAGRELOR VERSUS CLOPIDOGREL AFTER THROMBOLYTIC THERAPY IN PATIENTS WITH ST- ELEVATION MYOCARDIAL INFARCTION: A RANDOMIZED CLINICAL TRIAL Otavio Berwanger, MD, PhD - On behalf of the TREAT Trial Steering

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with

More information

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D. Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice Rohan Dharmakumar, Ph.D. Director, Translational Cardiac Imaging Research Associate Director, Biomedical Imaging

More information

HFpEF, Mito or Realidad?

HFpEF, Mito or Realidad? HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY

More information

New Insights on Reperfusion Choices Implications of STREAM. Paul W Armstrong MD

New Insights on Reperfusion Choices Implications of STREAM. Paul W Armstrong MD New Insights on Reperfusion Choices Implications of STREAM ESC STEMI Satellite Symposium August 31 2014 Aligning Optimal Care to Time Place and Person Paul W Armstrong MD Disclosure Statement Paul W. Armstrong

More information

Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location

Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Heart Online First, published on April 14, 2005 as 10.1136/hrt.2005.060152 1 Primary PCI versus thrombolytic therapy: long-term follow-up according to infarct location Short running head: Anterior infarction

More information

Heart Failure. Guillaume Jondeau Hôpital Bichat, Paris, France

Heart Failure. Guillaume Jondeau Hôpital Bichat, Paris, France Heart Failure Guillaume Jondeau Hôpital Bichat, Paris, France Epidemiology Importance of PEF Europe I-PREFER study. Abstract: 2835 Prevalence of HF Preserved LV systolic Function older (65 vs 62 y, p

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

Vest Prevention of Early Sudden Death Trial (VEST)

Vest Prevention of Early Sudden Death Trial (VEST) ACC Late Breaking Clinical Trials 2018 Vest Prevention of Early Sudden Death Trial (VEST) Jeffrey Olgin, MD, FACC Division of Cardiology, UCSF On behalf of the VEST Investigators Disclosures ClinicalTrials.gov

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Aldosterone Antagonism in Heart Failure: Now for all Patients?

Aldosterone Antagonism in Heart Failure: Now for all Patients? Aldosterone Antagonism in Heart Failure: Now for all Patients? Inder Anand, MD, FRCP, D Phil (Oxon.) Professor of Medicine, University of Minnesota, Director Heart Failure Program, VA Medical Center 111C

More information

Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine

Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine de Waha et al. Trials 2014, 15:249 TRIALS RESEARCH Open Access Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine Suzanne de Waha

More information

MULTIcentre evaluation of Single high-dose. acute myocardial infarction study

MULTIcentre evaluation of Single high-dose. acute myocardial infarction study MULTIcentre evaluation of Single high-dose Tirofiban bolus TiRofiban vs. versus with sirolimus eluting stent or barein metal stent in during primary PCI STEMI acute myocardial infarction study M. Valgimigli,

More information

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )

Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland

More information

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Ellis MD Dean J. Kereiakes MD and Gregg W. Stone MD for the ABSORB

More information

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION?

SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? SHOULD BETA BLOCKERS BE USED ROUTINELY IN POST MI PATIENTS WITH PRESERVED LV FUNCTION? Doron Zahger, MD Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion

More information

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of

More information

Subsequent management and therapies

Subsequent management and therapies ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY

More information

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D. Detection and Assessment of MI: Use of Imaging Methods Robert O. Bonow, M.D. Detection and Assessment of MI: Use of Imaging Methods Robert O. Bonow, M.D. No Relationships to Disclose Expert Consensus Document

More information

No conflict of interest to declare

No conflict of interest to declare Switch and Non-Switch in P2Y12 Inhibition: The Real-Life Use of Clopidogrel and Prasugrel in Patients with Acute Myocardial Infarction. Insights from the FAST MI 2010 Registry. F. Schiele (Besançon), E.

More information

CARDIAC. Keywords Cardiac magnetic resonance imaging. Acute myocardial infarction. Haemorrhage. Microvascular obstruction.

CARDIAC. Keywords Cardiac magnetic resonance imaging. Acute myocardial infarction. Haemorrhage. Microvascular obstruction. Eur Radiol (2014) 24:3277 3288 DOI 10.1007/s00330-014-3318-3 CARDIAC The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction

More information

STATINS EVALUATION IN CORONARY PROCEDURES AND REVASCULARIZATION

STATINS EVALUATION IN CORONARY PROCEDURES AND REVASCULARIZATION STATINS EVALUATION IN CORONARY PROCEDURES AND REVASCULARIZATION Otávio Berwanger, MD, FACS - On behalf of the SECURE Steering Committee and Investigators Trial Organization Trial Steering Committee Dr.

More information

Acute Myocardial Infarction

Acute Myocardial Infarction Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:

More information

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY ACUTE CORONARY SYNDROME PCI IN THE ELDERLY G.KARABELA MD.PhD ATHENS NAVAL HOSPITAL INTERVENTIONAL CARDIOLOGY DEPARTMENT NO CONFLICT OF INTEREST TO DECLAIRE Risk stratification in Αcute Coronary Syndrome.

More information